Sort Results:
List of Partnerships
CWHM/OWH Childhood Diarrhea |
|
CWHM signed a joint research agreement in 2010 with the Institute for One World Health to discover and develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in... |
Partner:
PATH/One World Health |
Eisiai Partners with Johns Hopkins Brain Science Institute |
|
Eisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint... |
Partner:
Eisiai Pharmaceuticals |
Elan and University of Cambridge Establish New Innovation Center |
|
University of Cambridge and Elan jointly established Cambridge - Elan Centre for Research Innovation and Drug Discovery. The new center will be based out of Cambridge and will focus primarily in... |
Partner:
Elan |
Evotec and Yale University form Open Innovation Alliance |
|
Evotec and Yale intend to leverage first rate science performed at Yale University together with Evotec's drug discovery infrastructure and expertise into highly innovative discovery approaches in... |
Partner:
Evotec AG |
Evotec and Yale University to collaborate on cancer therapy |
|
Evotec announced a research collaboration, TargetDBR (DNA Break Repair), with the laboratories of Prof. Peter Glazer and Prof. Ranjit Bindra at Yale School of Medicine. The objective of this... |
Partner:
Evotec AG |
GIBH/CWHM Malaria |
|
GIBH is a medical research institute affiliated with the Chinese Academy of Sciences. CWHM has been collaborating with GIBH scientists since 2010 on a project to discover and develop new medicines for... |
Partner:
Guangzhou Institute of Biomedicine and Health |
GSK and MD Anderson to co-develop new cancer therapeutics |
|
GlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants... |
Partner:
GlaxoSmithkline |
GSK and Yale to partner on drug discovery development |
|
GlaxoSmithKline (GSK) and Yale University will partner to design a new class of molecules to target disease-causing proteins. This is the latest in a string of deals between Yale’s academic... |
Partner:
GSK |
IBD Therapeutics Incubator |
|
IBD Therapeutics Incubator: Request for ProposalsThe Crohn’s & Colitis Foundation (Foundation) is dedicated to addressing the unmet needs of patients with inflammatory bowel diseases (IBD). The... |
Partner:
Crohn's & Colitis Foundation |
Janssen Partners with Evotec-Harvard Diabetes Collaboration Program |
|
Janssen Pharmaceutical a division of Johnson & Johnson has entered into partnership with Harvard University - Evotec's Diabetes program called CureBeta. Janssen will paying $300million in milestone... |
Partner:
Evotec |